| Stage |
Phase |
Principal Investigator |
Study prefix |
Study number |
Title (click hyperlink for more information) |
| III or IV | II | Anurag Singh, MD | I | 107807 | Randomized, Double- Blind, Placebo Controlled, Multi- Center, Phase II Trial of Selenomethionine as a Modulator of Efficacy and Toxicity of Chemoradiation in Locally Advanced Squamous Cell Carcinoma of the Head and Neck |
| I | I | Nestor Rigual, MD | I | 109307 | Phase I Trial of Photodynamic Therapy with HPPH (2-1[Hexyloxyethyl]-2-Devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and Stage I Carcinoma of the Oral Cavity |
| I | Nestor Rigual, MD | I | 119207 | Phase I Trial of Photodynamic Therapy with HPPH (2-1[hexyloxyethyl]-2-devinylpyropheophorbide-a) for Treatment of Dysplasia, Carcinoma in Situ and T1 Carcinoma of the Larynx |
| I | Nestor Rigual, MD | I | 74606 | A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) in Patients with Resectable, Primary or Recurrent Head and Neck Cancer |
| IIb | Maureen Sullivan, DDS | I | 146408 | Bowman Birk Inhibitor Concentrate and Oral Leukoplakia: A Randomized Phase IIb Trial - CLOSED with TREATMENT |
| Stage III or IV Squamous Cell Carcinoma | II | Anurag Singh, MD | NCG | 145908 | (RTOG 0619) A Randomized Phase II Trial of Chemoradiotherapy Versus Chemoradiotherapy and Vandetanib for High-Risk Postoperative Advanced Squamous Cell Carcinoma of the Head and Neck |
| Pilot | Anurag Singh, MD | I | 143108 | A Feasibility Study of Re-Irradiation Using Stereotactic Body Radiation Therapy (SBRT) and Cetuximab for Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN) |